RxDoctor Payments Data

Justin Phillingane

Podiatrist · Petersburg, VANPI 1548642788

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $62,500 of the $82,436 with a category attached, or 75.8%. Amgen accounts for 84.6% of it on its own, with 25 other manufacturers making up the rest. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,436in general payments, 2019–2025

Across 271 payments — averaging $304.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$70K
  • Kerecis Limited$4K
  • Bioventus LLC$3K
  • Stryker$2K
  • Fortis Surgical, LLC$1K
  • Smith+Nephew$1K
  • plus $1K from 20 others

What the payments were for

  • Consulting fees$7501%
  • Speaking & faculty fees$62,50076%
  • Travel & lodging$11,02013%
  • Food & beverage$6,9668%
  • Education$1,2001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,436 in reported general payments places this provider in the 95th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$684,833
Medicare patients
394
Services billed
2,196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate92$2,120
Diclofenac Sodium25$1,163
Gabapentin37$829
Duloxetine Hcl62$818
Pregabalin27$703
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$310
Terbinafine Hcl11$283
Doxycycline Hyclate32$241
Levofloxacin25$236
Ciclopirox19$216
Allopurinol28$170
Clotrimazole24$169
CiclopiroxCiclopirox Olamine11$153
Meloxicam11$98
Silver Sulfadiazine13$95

Paid to pharmacies, not to this prescriber.

Other podiatrist in Petersburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →